Aurobindo receives FDA approval for solifenacin succinate tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application solifenacin succinate tablets, 5mg, and 10mg.